- Investigator
- R. David Anderson
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Myocardial Infarction , 22 publications
- Myocardial Ischemia , 14 publications
- Coronary Artery Disease , 12 publications
- Coronary Disease , 9 publications
Research activity
Active clinical trials
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 18 Years - 90 Years
- Sexes
- All
This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham control treatment. A roll-in phase with a maximum of 10 subjects may occur.
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 21 Years - 90 Years
- Sexes
- All
My publications
Filter publications
113 publications
2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
Journal of the American Heart Association
Publisher's site2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Circulation: Cardiovascular Interventions
Publisher's site2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
New England Journal of Medicine
Publisher's site2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
Journal of the American Heart Association
PubMed • Publisher's site2020
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
The American Journal of Medicine
PubMed • Publisher's site